BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 7209360)

  • 21. Treatment outcomes and mortality of 94 patients with acromegaly.
    Trepp R; Stettler C; Zwahlen M; Seiler R; Diem P; Christ ER
    Acta Neurochir (Wien); 2005 Mar; 147(3):243-51; discussion 250-1. PubMed ID: 15627919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of extensively invasive (giant) prolactinomas with bromocriptine.
    Grebe SK; Delahunt JW; Feek CM
    N Z Med J; 1992 Apr; 105(931):129-31. PubMed ID: 1560924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocrine response after gamma knife-based stereotactic radiosurgery for secretory pituitary adenoma.
    Tinnel BA; Henderson MA; Witt TC; Fakiris AJ; Worth RM; Des Rosiers PM; Edmondson JW; Timmerman RD; Lo SS
    Stereotact Funct Neurosurg; 2008; 86(5):292-6. PubMed ID: 18758206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of pituitary tumors.
    Post KD; Muraszko K
    Neurol Clin; 1986 Nov; 4(4):801-31. PubMed ID: 3540586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of bromocriptine on pituitary tumour size.
    McGregor AM; Scanlon MF; Hall R; Hall K
    Br Med J; 1979 Sep; 2(6192):700-3. PubMed ID: 509071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Size reduction of extrasellar pituitary tumors during bromocriptine treatment.
    Wollesen F; Andersen T; Karle A
    Ann Intern Med; 1982 Mar; 96(3):281-6. PubMed ID: 7059088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical neuroendocrinology].
    Marek J
    Sb Lek; 1995; 96(4):333-8. PubMed ID: 8711379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of treatment for male prolactinomas].
    Iwai Y; Yamanaka K; Ishiguro T; Morikawa T; Matsuzaka Y; Komiyama M; Yasui T
    No Shinkei Geka; 2002 Dec; 30(12):1285-92. PubMed ID: 12491580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The treatment of acromegaly].
    Beauregard H; Somma M; Rasio E; Serri O; Aris-Jilwan N; Comtois R; Long H; Abribat T; Boucher A; Hardy J
    Union Med Can; 1993; 122(6):489-95. PubMed ID: 8303792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superiority of bromocriptine over pyridoxine in the treatment of patients with acromegaly or galactorrhea.
    Blum I; Segal S; Kaufman H; Sagiv M; Shalit M; Chowers I
    Isr J Med Sci; 1980 Jan; 16(1):12-6. PubMed ID: 7188934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical management of acromegaly with bromocriptine. Effects of continuous treatment for over three years.
    Besser GM; Wass JA
    Med J Aust; 1978 Nov; 2(3 Suppl):31-3. PubMed ID: 745579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas.
    Minniti G; Traish D; Ashley S; Gonsalves A; Brada M
    Clin Endocrinol (Oxf); 2006 May; 64(5):542-8. PubMed ID: 16649974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depot-bromocriptine treatment for prolactinomas and acromegaly.
    Grossman A; Ross R; Wass JA; Besser GM
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):231-8. PubMed ID: 3708874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid resolution of visual field defects and reduction in macroprolactinoma size with bromocriptine therapy. A case report.
    Kahn SE; Miller JL
    S Afr Med J; 1982 Oct; 62(19):696-9. PubMed ID: 7135127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of hormone-secreting pituitary microadenomas.
    Gáspár L; Kocsis J; Kemény A; Pásztor E; László FA
    Acta Med Hung; 1983; 40(2-3):107-24. PubMed ID: 6322100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of acromegaly. Results in 56 patients].
    del Pozo C; Webb SM; Oliver B; Tresserras P; de Leiva A
    Med Clin (Barc); 1990 Jan; 94(3):85-7. PubMed ID: 2314144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bromocriptine therapy].
    König MP
    Schweiz Med Wochenschr; 1981 Feb; 111(9):303-8. PubMed ID: 6111843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anti-tumorous effect of bromocriptine in prolactin-secreting adenomas. A case-report (author's transl)].
    Bigorgne JC; Rohmer V; Mercier P; Galland F
    Sem Hop; 1982 Mar; 58(11):679-82. PubMed ID: 6278614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pituitary adenomas in childhood and adolescence. Clinical analysis of 10 cases.
    De Menis E; Visentin A; Billeci D; Tramontin P; Agostini S; Marton E; Conte N
    J Endocrinol Invest; 2001 Feb; 24(2):92-7. PubMed ID: 11263478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors in the outcome of transsphenoidal surgery for prolactinoma and non-functioning pituitary tumour, including pre-operative bromocriptine therapy.
    Bevan JS; Adams CB; Burke CW; Morton KE; Molyneux AJ; Moore RA; Esiri MM
    Clin Endocrinol (Oxf); 1987 May; 26(5):541-56. PubMed ID: 3665118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.